Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized sars-cov-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted sars2-n501yma30 strain of sars-cov-2

HIGHLIGHTS

• who: Karen V. Kibler and collaborators from the Biodesign Center for Immunotherapy, Vaccines and Virotherapy, Arizona State University, Department of Pediatrics, University of Iowa, Iowa City, IA, USA have published the paper: Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501YMA30 Strain of SARS-CoV-2, in the Journal: Vaccines 2022, 10, 1172. of /2022/
• what: In this manuscript the authors show that intranasal immunization with a Washington strain spike expressed from a highly . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.